Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites

被引:29
作者
Belloso, W. H. [1 ,2 ]
Orellana, L. C. [3 ]
Grinsztejn, B. [4 ]
Madero, J. S. [5 ]
La Rosa, A. [6 ]
Veloso, V. G. [4 ]
Sanchez, J. [6 ]
Ismerio Moreira, R. [4 ]
Crabtree-Ramirez, B. [5 ]
Garcia Messina, O. [7 ]
Lasala, M. B. [8 ]
Peinado, J. [6 ]
Losso, M. H. [2 ,9 ]
机构
[1] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina
[2] CICAL, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Inst Calculo, RA-1053 Buenos Aires, DF, Argentina
[4] Fiocruz MS, Inst Pesquisa Clin Evandro Chagas, BR-21045900 Rio De Janeiro, Brazil
[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
[6] INMENSA, Lima, Peru
[7] Hosp Parmenio Pinero, Buenos Aires, DF, Argentina
[8] Hosp Clin Jose San Martin, Buenos Aires, DF, Argentina
[9] Hosp JM Ramos Mejia, Buenos Aires, DF, Argentina
关键词
AIDS; cardiovascular disease; CD4 cell lymphocyte count; cohort studies; liver diseases; neoplasms; ACTIVE ANTIRETROVIRAL THERAPY; MORTALITY; RISK; DEATH; IMMUNODEFICIENCY; DISEASE; VIRUS; HAART; INDIVIDUALS; COUNTRIES;
D O I
10.1111/j.1468-1293.2010.00824.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective Acquired immune deficiency appears to be associated with serious non-AIDS (SNA)-defining conditions such as cardiovascular disease, liver and renal insufficiency and non-AIDS-related malignancies. We analysed the incidence of, and factors associated with, several SNA events in the LATINA retrospective cohort. Materials and methods Cases of SNA events were recorded among cohort patients. Three controls were selected for each case from cohort members at risk. Conditional logistic models were fitted to estimate the effect of traditional risk factors as well as HIV-associated factors on non-AIDS-defining conditions. Results Among 6007 patients in follow-up, 130 had an SNA event (0.86 events/100 person-years of follow-up) and were defined as cases (40 with cardiovascular events, 54 with serious liver failure, 35 with non-AIDS-defining malignancies and two with renal insufficiency). Risk factors such as diabetes, hepatitis B and C virus coinfections and alcohol abuse showed an association with events, as expected. The last recorded CD4 T-cell count prior to index date (P=0.0056, with an average difference of more than 100 cells/mu L) and area under the CD4 cell curve in the year previous to index date (P=0.0081) were significantly lower in cases than in controls. CD4 cell count at index date was significantly associated with the outcome after adjusting for risk factors. Conclusions The incidence and type of SNA events found in this Latin American cohort are similar to those reported in other regions. We found a significant association between immune deficiency and the risk of SNA events, even in patients under antiretroviral treatment.
引用
收藏
页码:554 / 564
页数:11
相关论文
共 35 条
[1]  
[Anonymous], 2008, Modern epidemiology
[2]   Poor initial CD4+recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseases [J].
Baker, Jason V. ;
Peng, Grace ;
Rapkin, Joshua ;
Krason, David ;
Reilly, Cavan ;
Cavert, Winston P. ;
Abrams, Donald I. ;
MacArthur, Rodger D. ;
Henry, Keith ;
Neaton, James D. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2008, 48 (05) :541-546
[3]   CD4+count and risk of non-AIDS diseases following initial treatment for HIV infection [J].
Baker, Jason V. ;
Peng, Grace ;
Rapkin, Joshua ;
Abrams, Donald I. ;
Silverberg, Michael J. ;
MacArthur, Rodger D. ;
Cavert, Winston P. ;
Henry, W. Keith ;
Neaton, James D. .
AIDS, 2008, 22 (07) :841-848
[4]   AIDS in Latin America:: assessing the current status of the epidemic and the ongoing response [J].
Bastos, Francisco I. ;
Caceres, Carlos ;
Galvao, Jane ;
Veras, Maria Amelia ;
Castilho, Euclides Ayres .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2008, 37 (04) :729-737
[5]   Optimizing resource allocation for HIV/AIDS prevention programmes: an analytical framework [J].
Bautista-Arredondo, Sergio ;
Gadsden, Paola ;
Harris, Jeffrey E. ;
Bertozzi, Stefano M. .
AIDS, 2008, 22 :S67-S74
[6]  
Beral V, 2004, AIDS, V18, P51, DOI [10.1097/01.aids.0000096908.73209.5d, 10.1097/00002030-200401020-00006]
[7]  
Bottecchia M, 2007, CURR OPIN INFECT DIS, V20, P621
[8]   Access to antiretroviral treatment in Latin American countries and the Caribbean [J].
Chequer, P ;
Cuchí, P ;
Mazin, R ;
Calleja, JMG .
AIDS, 2002, 16 :S50-S57
[9]  
CRABTREERAMIREZ B, BASELINE CHARACTERIS
[10]   Comparisons of causes of death and mortality rates among HIV-infected persons - Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras [J].
Crum, NF ;
Riffenburgh, RH ;
Wegner, S ;
Agan, BK ;
Tasker, SA ;
Spooner, KM ;
Armstrong, AW ;
Fraser, S ;
Wallace, MR .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 41 (02) :194-200